Technology
advancement and globalization are two major forces affecting private equity
investors. While private equity firms have capitalized on the advancement
of technology, and in many cases have made advancement possible, private equity
firms are only now beginning to seize opportunities presented by globalization.
| |
| Venture capital firms are now : |
|
●
|
Seeking
new investment oportunities in emeringmarkets |
|
●
|
Pressuring portfolio firms to outsource labor intensive activies to low cost centers |
|
| Buyout firms are now : |
|
● |
Investing in many enterprises which are struggling because of Chinese competition |
|
● |
Increasingly dealing with China strategy in the boardroom |
|
● |
Pursuing state owned asset privatizaitons and other opportunities in China |
|
|
|
|
| |
|
|
In order to realize significant returns, sustain long-term
franchises, and build global businesses, private equity investors must understand
and seize the opportunities that China offers. However, along with opportunity
comes risk: cultural, legal, and informational. China has a demanding, dynamic
business environment that sometimes takes the flavor of the ‘wild west’.
Success in China depends upon trusted local partners who can
bridge cultures, have a distinct sense of strategy, and focus on long-term
time horizons.
GB's private equity services
GB is the only professional services firm focused on bio-business
in China. Our industry expertise ranges across biotechnology, pharmaceuticals,
healthcare and chemicals. Our experience includes valuation, due diligence,
deal flow and agency, negotiation, portfolio management, and new fund creation.
We are further distinguished through:
Primary focus on businesses that are impacted in some way
by biotechnology
Proprietary information flow from an exclusive database and
network
Unique service mix and ability to add value across the investment
chain
Understanding of Chinese and Western culture, strategy, business
practice, and science
GB provides life cycle and lead investment services to its
private equity clients.
Investment lifecycle services
GB portfolio company services
GB provides a variety of services for companies in different
stages of their development in China. We help companies grow their businesses
through market penetration, cost reduction, and product/pipeline acquisition.
Our client services include:
Market research
China strategy development
Implementation assistance
